Published February 1, 2025 | Version v1

Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study.

Description

Abstract not available

Files

Chimeric antigen receptor T-cell therapy outcomes in T cellhistiocyte-rich large B-cell lymphoma.pdf